SASP-Driven Vascular Aging: Unraveling The Transcriptional Nexus In Endothelial Senescence And Cardiovascular Disease
As we age, our bodies undergo many changes, and one significant factor contributing to age-related diseases, especially those affecting our heart and blood vessels, is something called “cellular senescence.” Imagine certain cells in your body deciding to retire – they stop dividing, but they don’t die. Instead, these “senescent” cells become a bit like grumpy neighbors, constantly releasing a cocktail of inflammatory molecules, growth factors, and enzymes into their surroundings. This harmful cocktail is known as the Senescence-Associated Secretory Phenotype, or SASP.
This constant release of inflammatory signals from SASP has a profound impact on our blood vessels. It contributes to what scientists call “vascular aging,” a process characterized by the stiffening of arteries and the dysfunction of the endothelial cells that line our blood vessels. This dysfunction can lead to a range of cardiovascular problems, including atherosclerosis (hardening of the arteries), high blood pressure, and even heart failure.
The SASP essentially creates a state of chronic, low-grade inflammation throughout the body, which damages tissues and accelerates the aging process in our vascular system. Understanding how these senescent cells and their SASP contribute to vascular aging is crucial because it opens up new avenues for treatment. Researchers are now exploring therapies that either selectively remove these senescent cells (called senolytics) or modify the harmful substances they release (called senomorphics). These approaches hold promise for combating age-related cardiovascular diseases and promoting healthier aging.
Source: link to paper